Clinical Trial Detail

NCT ID NCT01331291
Title Bosutinib in Adult Patients With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

glioblastoma multiforme

Therapies

Bosutinib

Age Groups: adult

No variant requirements are available.